All News

The American Society of Clinical Oncology has endorsed the AUA/American Society for Radiation Oncology guideline on the use of adjuvant and salvage radiotherapy after prostatectomy.

Jonathan Henderson, MD, a urologist in a large group practice in Shreveport, LA, says he and his partners have seen the nationwide proliferation of non-urologist, community-based men’s health centers. And they believe, he says, patients are not being properly served.

A panel comprised of a highly experienced health care consultant and two group practice leaders finds that large group practices are likely to be one of the few entities allowing urologists or other specialists a refuge from the current chaos in the American health care system.

Two recently published studies provide new insight on cardiovascular morbidity and mortality associated with androgen deprivation therapy in men with prostate cancer.

Physician assistants are expected to play a larger role in urology practices amid a shortage of urologists. Here’s a statistical look at PAs in urology (and medicine in general), provided by Aaron Milbank, MD, and Ken Mitchell, MPAS, of Metro Urology during the Large Urology Group Practice Association annual meeting in Chicago.

Despite another anti-prostate cancer screening message (this one from north of the border), many U.S. urologists have already taken a more individualized approach to screening and will likely continue to do so.

When provisions of the Affordable Care Act (ACA) related to the expansion of Medicaid to low-income childless adults took effect in January 2014, 25 states and the District of Columbia had approved laws to broaden their programs' eligibility requirements. Since then, under pressure from various interests groups, including state hospital associations, lawmakers in at least three more states-Iowa, Michigan, and Pennsylvania-expanded their health care safety net programs and thereby gained access to federal dollars that would have otherwise been left on the table.

A vast majority of top-ranked consumer health websites disagree with the U.S. Preventive Services Task Force’s recommendation against screening for prostate cancer, according to a study presented at the American College of Surgeons clinical congress in San Francisco.

A number of prominent urologists are among the signers of a letter applauding the FDA for holding a workshop on female sexual dysfunction.

This video demonstrates the step-by-step process, including positioning, ventral phalloplasty, and a modified “no-touch” technique, utilized in the placement of an inflatable penile prosthesis.

These videos demonstrate the difference in anatomic approach between a single penoscrotal and double perineal/penoscrotal incision technique for simultaneous placement of the inflatable penile prosthesis and artificial urinary sphincter.

This video first demonstrates the ventral phalloplasty and then shows the placement of an inflatable penile prosthesis.

This video demonstrates a technique for placing an AMS Spectra penile prosthesis (American Medical Systems) using a subcoronal incision.

The 2014 Urology Times “State of the Specialty” survey shows that urologists remain frustrated with over-regulation by government, control of fees, meaningful use (meaningless use?), and a host of other rules that many argue add nothing to the quality of patient care.

This video demonstrates a unique, retractor-less approach to penoscrotal placement of the AMS 700 penile prosthesis (American Medical Systems)

The number of sexual partners a man has could be related to risk of being diagnosed with prostate cancer, Canadian researchers report.

Urologists know the International Classification of Diseases-10 (ICD-10) goes into effect Oct. 1, 2015. Whether they understand the transition’s impact and what they need to do to fully prepare are questionable.

Members of the Large Urology Group Practice Association will gather Nov. 6-8 in Chicago for the association’s annual meeting, and Urology Times will be delivering highlights of the meeting straight to your inbox.

In this interview, Eugene Y. Rhee, MD, MBA, discusses violent acts committed against urologists, the challenges of collecting and sharing data on potentially dangerous patients, and what some institutions are doing to protect their practices.

Research on the quality of bladder biopsy and bladder cancer survival point to problems of suboptimal biopsies and incorrect tumor staging, researchers say.

Inflammation may be the missing link between vitamin D and prostate cancer, new study findings from the University of Colorado Cancer Center in Denver suggest.

A study presented at the American Society for Reproductive Medicine annual meeting in Honolulu suggests a possible link between the recession of 2007-2009 and increasing vasectomy rates in the United States.

Papers examining the effects of diet and substance use on male fertility presented at the recently concluded American Society for Reproductive Medicine annual meeting in Honolulu may appear to provide conflicting findings, but an expert in andrology says the observational studies don’t tell the complete story.

As health care payment policy is changing at a rapid pace, many have found that partnership with the government is the best way to affect overall payment policy.

Urologists across the country describe treatment options for large kidney and ureteral stones.

In this article, Robert A. Dowling, MD, reviews the challenges of implementing active surveillance in a practice as well as ways to surmount these obstacles.

If an estate owner, based on his current financial situation, is not willing or able to contribute an entire financial asset during his lifetime, a split-interest, deferred gift is something to consider.

In separate actions, the FDA allowed the marketing of a urinary prosthesis for women and approved a supplemental new drug application for a lymphatic mapping agent.

Victor W. Nitti, MD, has been appointed by the AUA Board of Directors as the new Chair of the AUA Office of Education.

Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a draft local coverage determination for the Prolaris prostate cancer test, Myriad Genetics, Inc. announced.